Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
ASH Highlights
Filter by Topic
ASH 2015
Precision Medicine and Immunotherapy Highlighted at ASH 2017
By
Wayne Kuznar
Conference Correspondent
,
Web Exclusives
,
ASH Highlights
Read More ›
First-in-Human CAR T-Cell Trial Shows Activity in Multiple Myeloma
By
James Kochenderfer, MD
ASH 2015
,
ASH Highlights
Read More ›
Another Study Shows Benefit with a Pediatric Regimen in Young Adults with ALL
By
Daniel DeAngelo, MD, PhD
ASH Highlights
,
ASH 2015
Read More ›
Venetoclax: Strong Showing in CLL
By
Stephan Stilgenbauer, MD
ASH Highlights
,
ASH 2015
Read More ›
CAR T-Cell Therapy Highly Active in Various Hematologic Malignancies
By
James Kochenderfer, MD
ASH Highlights
,
ASH 2015
Read More ›
Checkpoint Inhibitors in Lymphoma: A New Universe
By
Philippe Armand, MD
ASH Highlights
,
ASH 2015
Read More ›
Idelalisib Combined with Bendamustine/Rituximab Boosts Survival in CLL
By
Andrew Zelenetz, MD
ASH Highlights
,
ASH 2015
Read More ›
Ibrutinib a New Standard of Care for Elderly CLL Patients
ASH Highlights
,
ASH 2015
Read More ›
In Newly Diagnosed Myeloma Patients, Triplets Preferred
By
Brian G.M. Durie, MD
ASH Highlights
,
ASH 2015
Read More ›
Midostaurin: First Targeted Therapy in AML Is Potentially Practice Changing
ASH Highlights
,
ASH 2015
Read More ›
Page 1 of 2
1
2